Register | Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | ESMO 2018 Congress

Specialties >>

Acute Myeloid Leukemia
Biosimilars
Bladder Cancer
Brain Cancer
Breast Cancer
Chronic Lymphocytic Leukemia
Colorectal Cancer
Follicular Lymphoma
Gastric Cancer
Gastrointestinal Cancers
Genitourinary Cancers
Gynecologic Cancers
Head and Neck Cancers
Hematology
Hepatocellular Carcinoma
Immunotherapy
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Myeloproliferative Neoplasms
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Soft Tissue Sarcoma
Thyroid Cancers

Partners >>

Dialogues in Diagnostics
Differential Diagnosis
Case-Based Peer Perspectives
Email Sign-Up

Latest NewsMORE >>

Evaluating the Role of the Gut Microbiome to Bolster Immunotherapy Response in Melanoma
October 17, 2018
Hassane M. Zarour, MD, discussed the research surrounding manipulation of the gut microbiome to improve response to immunotherapy in melanoma and other tumor types.
Read more >>
Induction Chemo Turns Cold Tumors Hot in Metastatic TNBC
October 17, 2018
Ibrutinib and Obinutuzumab Combo Granted Priority Review by FDA For Frontline CLL
October 17, 2018
Burstein Examines Predictive Value in Genomic Tests for Breast Cancer
October 17, 2018
Olaparib Granted Orphan Drug Designation by FDA for Pancreatic Cancer
October 17, 2018

Videos

Expert Discusses How Negative Trial Impacted Field of mCRC
Combination Encorafenib Plus Binimetinib in Patients With Melanoma
Overview of Advances in Recent Years for Patients With AML
Current Options for Frontline Treatment of CLL

Case Studies

Managing Extranodal MZL
Impressions of a Case of Stage 4 GEJ Cancer
AML: A Case of Myelodysplasia-Related Changes
A Case of Immune Thrombocytopenia

Latest JournalAll Journals >>

Targeted Therapies in Oncology October 2018
Targeted Therapies in Oncology
Induction Chemo Turns Cold Tumors Hot in Metastatic TNBC
Tumor Mutational Burden Arises as an Actionable Biomarker in NSCLC
NCCN Creates New Guidelines for Rare Gestational Trophoblastic Disease
Clinical Implications for Inherited BRCA Mutations Are Explored in Ovarian Cancer
IO Combo Shows Potential in Persistent Ovarian Cancer
Liver Cancer Treatment Paradigm Undergoing Major Overhaul
MORE >>
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.